Opportunities and challenges following approval of resmetirom for MASH liver disease.
Jeffrey Victor LazarusDana Ivancovsky WajcmanHenry E MarkZobair M YounossiChristopher J KopkaNevin CohenMeena B BansalMichael BetelPaul Noel BrennanPublished in: Nature medicine (2024)
Keyphrases